Given the resilience of multiple Rac1-driven cells to BRAFi/MEKi treatment, we wondered whether these cells might be truly ERK-independent, as previously suggested for certain classes of Rac1/PAK-driven, BRAFi/MEKi-resistant melanoma cells [5]. This evidence concerns the gene RAC1 and melanoma.